Skip to main content
SpringerLink
Log in

Effects of Growth Hormone on Sodium Homeostasis

  • Chapter
Growth Hormone And The Heart

Part of the book series: Endocrine Updates ((ENDO,volume 9))

  • 106 Accesses

Abstract

Total body water constitutes about 60% of total body weight and of this, 55% is intracellular and 45% extracellular. The extracellular fluid compartment is further divided into plasma, interstitial fluid, lymph, and transcellular fluids. Since sodium (Na) is the predominant extracellular cation, regulation of extracellular volume (ECV) is tightly linked to adjustments of body Na content. The kidneys are the major organ responsible for fluid and Na homeostasis. Glomerular filtration rate (GFR) and renal plasma flow (RPF) have direct effects on the filtered load of Na, while subsequent tubular Na reabsorption is regulated chiefly by the renin-angiotensin-aldosterone system. Other hormones including atrial natriuretic peptide and antidiuretic hormone also play important roles in fluid and Na homeostasis. Growth hormone (GH) is the most abundant pituitary hormone in the adult pituitary gland. After cessation of longitudinal growth following puberty, GH continues to play a vital role in the regulation of substrate metabolism and body composition in adult life. Direct metabolic effects of GH include the stimulation of lipolysis, fat oxidation and hepatic glucose output. The anabolic actions of GH are mediated by insulin-like growth factor I (IGF-I) which promotes protein synthesis and reduces protein oxidation. Another well-known effect of GH is fluid and Na retention. Bierring and Nielsen in 1922 first reported fluid retention in rats given anterior pituitary extracts (1). The same phenomenon was observed during administration of human GH (hGH) in man by Ikkos et al (2) and later confirmed by other investigators (3-7). Further research was restricted by limited supply of hGH and the concern of possible contamination of hGH extracts by unknown bioactive substances. The availability of recombinant hGH, together with the emergence of new assays and metabolic investigative tools in the past decade, have advanced the understanding of the fluid and Na regulatory effects of GH. This chapter will review the physiological mechanisms behind the antinatriuretic and antidiuretic effects of GH, as well as the associated therapeutic implications on GH administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bierring E, Nielsen E. The composition of the tissues of albino rats treated with alkaline anterior pituitary extracts. Biochem J 1932;26:1015–1021.

    PubMed  CAS  Google Scholar 

  2. Ikkos D, Luft R, Gemzell CA. The effect of human growth hormone in man. Acta Endocrinol (Copenh) 1959;32:341–361.

    CAS  Google Scholar 

  3. Hutchings JJ, Escamilla RF, Deamer WC, Li CH. Metabolic changes produced by human growth hormone in a pituitary dwarf. J Clin Endocrinol Metab 1959;19:759–769.

    Article  PubMed  CAS  Google Scholar 

  4. Henneman PH, Forbes AP, Moldawer M, Dempsey EF, Carroll EL. Effects of human growth hormone in man. J Clin Invest 1960;37:1223–1245.

    Article  Google Scholar 

  5. Beck JC, McGarry EE, Dyrenfurth I, Yenning EH. Metabolic effects of human and monkey growth hormone in man. Science 1957;125:884–885.

    Article  PubMed  CAS  Google Scholar 

  6. Venning EH, Dyrenfurth VL, Giroud JP, Beck JC. Effect of growth hormone on aldosterone secretion. Metabolism 1956;5:697–702.

    PubMed  CAS  Google Scholar 

  7. Biglieri EG, Watlington CO, Forsham PH. Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab 1961;21:361–370.

    Article  CAS  Google Scholar 

  8. Aloia JF, Roginsky MS, Jowsey J, Dombrowski CS, Shukla KK, Cohn SH. Skeletal metabolism and body composition in acromegaly. J Clin Endocrinol Metab 1972;35:543–551.

    Article  PubMed  CAS  Google Scholar 

  9. McLellan AR, Connell JMC, Beastall GH, Teasdale G, Davies DL. Growth hormone, body composition and somatomedin C after treatment in acromegaly. Q J Med 1988;69:997–1008.

    PubMed  CAS  Google Scholar 

  10. Ritchie CM, Sheridan B, Fraser R, et al. Studies on the pathogenesis of hypertension in Cushing’s disease and acromegaly. Q J Med 1990;76:855–867.

    PubMed  CAS  Google Scholar 

  11. Falkheden T, Sjogren B. Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly. Acta Endocrinol (Copenh) 1964;46:80–88.

    CAS  Google Scholar 

  12. Strauch G, Lego A, Therain F, Bricaire H. Reversible plasma and red blood cell volume increases in acromegaly. Acta Endocrinol (Copenh) 1977;85:465–478.

    CAS  Google Scholar 

  13. O’Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KKY. Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 1994;78:381–386.

    Article  PubMed  Google Scholar 

  14. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson B-A. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone defiency. Clin Endocrinol 1993;38:63–71.

    Article  CAS  Google Scholar 

  15. Moller J, Frandsen E, Fisker S, Jorgensen JOL, Christiansen JS. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol 1996;44:533–539.

    Article  CAS  Google Scholar 

  16. Hoffman DM, O’Sullivan AJ, Freund J, Ho KKY. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995;80:72–77.

    Article  PubMed  CAS  Google Scholar 

  17. Ho KKY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 1990;39:133–137.

    Article  PubMed  CAS  Google Scholar 

  18. Moller J, Moller N, Frandsen E, Wolthers T, Jorgensen JOL, Christiansen JS. Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans. Am J Physiol 1997;272:E 803–808.

    Google Scholar 

  19. Hoffman DM, Crampton L, Sernia C, Nyugen TV, Ho KKY. Stort term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 1996;81:1123–1128.

    Article  PubMed  CAS  Google Scholar 

  20. Harris PJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol 1985;248:F 621–630.

    Google Scholar 

  21. Venning EH, Lucius OJ. Effect of growth hormone on the biosynthesis of aldosterone in the rat. Endocrinology 1962;20:486–491.

    Article  Google Scholar 

  22. Cushman P, Alter S, Hilton JG. Effects of various growth hormone preparations on dog adrenal cortical secrtetion. Endocrinology 1966;78:971–975.

    Article  PubMed  CAS  Google Scholar 

  23. Cuneo RC, Saloman F, Wilmshurst P, et al. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991;81:587–592.

    PubMed  CAS  Google Scholar 

  24. Moller J, Jorgensen JOL, Moller N, Hansen KW, Pedersen EB, Christiansen JS. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 1991;72:768–772.

    Article  PubMed  CAS  Google Scholar 

  25. Wyse B, Waters M, Sernia C. Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats. Am J Physiol 1993;265:E 332–339.

    Google Scholar 

  26. McCaa RE, Montalvo JM, McCaa CS. Role of growth hormone in the regulation of aldosterone biosynthesis. J Clin Endocrinol Metab 1978;46:247–253.

    Article  PubMed  CAS  Google Scholar 

  27. Ludens JH, Bach RR, Williamson HE. Characteristics of the antinatriuretic action of growth hormone. Proc Soc Exp Biol Med 1969;130:1156–1158.

    PubMed  CAS  Google Scholar 

  28. Kelly JJ.1993 in Garvan Institute of Medical Research, pp. 16, University of New South Wales, Sydney, Australia

    Google Scholar 

  29. Falkheden T. Renal function following hypophysectomy in man. Acta Endocrinol (Copenh) 1963;42:571–590.

    Google Scholar 

  30. Falkheden T, Wickbom I. Renal function and size following hypophysectomy in man. Acta Endocrinol (Copenh) 1965;48:348–354.

    CAS  Google Scholar 

  31. Luft R, Sjogren B. The significance of the adenohypophysis, adrenal cortex, and thyroid in renal function in man. Acta Endocrinol (Copenh) 1950;4:351–362.

    CAS  Google Scholar 

  32. Christiansen JS, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving H-H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981;11:487–490.

    Article  PubMed  CAS  Google Scholar 

  33. Jorgensen JO, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in OH-deficient adults. Lancet 1989;1:1221–1225.

    Article  PubMed  CAS  Google Scholar 

  34. Rogers SA, Hammerman MR. Growth hormone activates phopholipase C in proximal tubular basolateral membranes from the canine kidney. Proc Natl Acad Sci USA 1989;86:6363–6366.

    Article  PubMed  CAS  Google Scholar 

  35. Hirschberg R, Kopple JD. Effects of growth hormone on GFR and renal plasma flow in man. Kidney hit 1987;32 (Suppl 22):S 21–24.

    Google Scholar 

  36. Guler H, Eckardt K, Zapf J, Bauer C, Froesch ER. Insulin-like growth factor-1 increases glomerular filtration rate and renal plasma flow in man Acta Endocrinol (Copenh) 1989;121:101–106.

    CAS  Google Scholar 

  37. Guler H, Schmid C, Zapf J, Froesch ER. Effect of recombinant insulin-like growth factor-1 on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 1989;86:2868–2872.

    Article  PubMed  CAS  Google Scholar 

  38. Cuneo RC, Salomon FS, Wilmshurst P, et al. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991;81:587–592.

    PubMed  CAS  Google Scholar 

  39. Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1996;77:1671–1676.

    Article  Google Scholar 

  40. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I. February Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 1995;80:659–666.

    Article  PubMed  CAS  Google Scholar 

  41. Thuesen L, Jorgensen JOL, Muller JR, et al. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol 1994;41:615–620.

    Article  CAS  Google Scholar 

  42. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 1985;314:264–266.

    Article  PubMed  CAS  Google Scholar 

  43. Weil J, Lang RE, Suttmann H, Rampf U, Bidlingmaier F, Gerzer R. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading. Klin Wochenschr 1985;63:1265–1268.

    Article  PubMed  CAS  Google Scholar 

  44. Dunn BR, Ichikawa I, Pfeffer JM, Troy JL, Brenner BM. Renal and systemic haemodynamic effects of synthetic atrial natriuretic peptide in the anaesthetised rat. Circ Res 1986;59:237–246.

    Article  PubMed  CAS  Google Scholar 

  45. McKnight JA, McCance DR, Hadden DR, et al. Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly. Clin Endocrinol 1989;31:431–438.

    Article  CAS  Google Scholar 

  46. De Fronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845–855.

    Article  Google Scholar 

  47. De Fronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976;58:83–90.

    Article  Google Scholar 

  48. De Fronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 1981;21:165–171.

    Google Scholar 

  49. Carroll PV, Christ ER, Members of Growth Hormone Research Society Scientific Committee, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83:382–395.

    Article  PubMed  CAS  Google Scholar 

  50. Salomon F, Cuneo RC, Hesp RC, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797–803.

    Article  PubMed  CAS  Google Scholar 

  51. Whitehead HM, Boreham C, Mcllrath EM. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45–52.

    Article  CAS  Google Scholar 

  52. Binnerts A, Swart GR, Wilson JHP, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 1992;37:79–87.

    Article  CAS  Google Scholar 

  53. Jorgensen JOL. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev 1991;12:189–208.

    Article  PubMed  CAS  Google Scholar 

  54. Cuneo RC, Judd S, Wallace JD, et al. The Australian multicenter trial of GH treatment in GH-deficient adults. J Clin Endocrinol Metab 1998;83:107–116.

    Article  PubMed  CAS  Google Scholar 

  55. Drake WM, Coyte D, Camacho-Hubner C, et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:3913–3919.

    Article  PubMed  CAS  Google Scholar 

  56. Baum HBA, Biller BMK, Finkelstein JS, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Annals of Internal Medicine 1996;125:883–890.

    PubMed  CAS  Google Scholar 

  57. Moller J, Jorgensen JOL, Lauersen T, et al. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol 1993;39:403–8.

    Article  CAS  Google Scholar 

  58. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996;81:1371–1377.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pituitary Research Unit, Garvan Institute of Medical Research, St. Vincent’s Hospital, Sydney, Australia

    Grace Y. W. Kam, Troels Wolthers & Ken K. Y. Ho

Authors
  1. Grace Y. W. Kam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Troels Wolthers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken K. Y. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Endocrine Section Department of Internal Medicine, University of Brescia, Italy

    Andrea Giustina M.D.  & Filippo Manelli M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kam, G.Y.W., Wolthers, T., Ho, K.K.Y. (2001). Effects of Growth Hormone on Sodium Homeostasis. In: Giustina, A., Manelli, F. (eds) Growth Hormone And The Heart. Endocrine Updates, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1579-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1579-1_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5624-0

  • Online ISBN: 978-1-4615-1579-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation